MAMOLO, MARIA GRAZIA
 Distribuzione geografica
Continente #
NA - Nord America 10.748
EU - Europa 7.797
AS - Asia 5.954
SA - Sud America 635
AF - Africa 137
Continente sconosciuto - Info sul continente non disponibili 27
OC - Oceania 6
Totale 25.304
Nazione #
US - Stati Uniti d'America 10.644
IT - Italia 3.078
SG - Singapore 2.022
CN - Cina 1.570
SE - Svezia 1.318
UA - Ucraina 889
HK - Hong Kong 519
BR - Brasile 516
VN - Vietnam 507
KR - Corea 504
FR - Francia 414
FI - Finlandia 350
DE - Germania 342
TR - Turchia 336
PL - Polonia 334
RU - Federazione Russa 262
GB - Regno Unito 240
BG - Bulgaria 155
IE - Irlanda 151
IN - India 146
NL - Olanda 94
JP - Giappone 52
CA - Canada 51
AR - Argentina 47
BD - Bangladesh 37
BE - Belgio 37
MY - Malesia 37
MA - Marocco 36
ZA - Sudafrica 36
SA - Arabia Saudita 33
MX - Messico 31
CH - Svizzera 26
EU - Europa 26
SN - Senegal 25
PK - Pakistan 22
EC - Ecuador 21
ES - Italia 21
ID - Indonesia 20
IQ - Iraq 20
AT - Austria 16
PH - Filippine 14
IR - Iran 13
CL - Cile 12
CO - Colombia 11
IL - Israele 11
AZ - Azerbaigian 10
CZ - Repubblica Ceca 10
RO - Romania 10
TW - Taiwan 10
UZ - Uzbekistan 10
EG - Egitto 9
PY - Paraguay 9
KE - Kenya 8
UY - Uruguay 8
GR - Grecia 7
HR - Croazia 7
KZ - Kazakistan 7
NP - Nepal 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
DK - Danimarca 6
JO - Giordania 6
TH - Thailandia 6
LT - Lituania 5
OM - Oman 5
PS - Palestinian Territory 5
TN - Tunisia 5
AL - Albania 4
ET - Etiopia 4
KG - Kirghizistan 4
LV - Lettonia 4
PA - Panama 4
RS - Serbia 4
TT - Trinidad e Tobago 4
AO - Angola 3
AU - Australia 3
BH - Bahrain 3
CR - Costa Rica 3
HU - Ungheria 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
SV - El Salvador 3
AM - Armenia 2
BO - Bolivia 2
CI - Costa d'Avorio 2
DZ - Algeria 2
GT - Guatemala 2
HN - Honduras 2
MK - Macedonia 2
PE - Perù 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GN - Guinea 1
IS - Islanda 1
Totale 25.289
Città #
Woodbridge 1.248
Singapore 1.221
Ann Arbor 1.209
Ashburn 779
Trieste 770
Jacksonville 768
Houston 698
Chandler 689
San Jose 559
Fairfield 509
Hong Kong 502
Seoul 494
Hefei 469
Wilmington 425
Beijing 414
Izmir 300
Princeton 285
Dallas 256
Boardman 234
Seattle 200
Milan 186
Warsaw 182
Chicago 180
Columbus 178
Ho Chi Minh City 161
Dearborn 157
Sofia 154
Dublin 148
Cambridge 145
Los Angeles 140
Lauterbourg 138
Zgierz 136
Rome 117
Buffalo 107
Hanoi 106
Moscow 95
Helsinki 89
The Dalles 86
Santa Clara 61
Frankfurt am Main 56
Verona 51
São Paulo 47
San Diego 46
Düsseldorf 45
Munich 44
Tokyo 44
New York 41
Bremen 38
Catania 37
Des Moines 37
Grafing 35
Nanjing 35
Brussels 34
Jinan 34
Naples 34
Turin 34
Messina 32
Orem 32
Redwood City 32
Kunming 31
Shanghai 30
Da Nang 29
Bologna 27
Casablanca 27
London 27
Guangzhou 26
Dakar 25
Norwalk 25
Phoenix 25
Chennai 24
Council Bluffs 24
Florence 22
Atlanta 21
Cagliari 21
Mestre 21
Rio de Janeiro 21
Toronto 21
Bari 20
Mumbai 20
Washington 20
Falls Church 19
Haiphong 17
Perugia 17
Tianjin 17
Brooklyn 16
New Delhi 16
Padova 16
Palermo 16
Dammam 15
Denver 15
Johannesburg 15
Sacile 15
Bern 14
Brescia 14
Manchester 14
Shenyang 14
Venice 14
Zhengzhou 14
Amsterdam 13
Montreal 13
Totale 16.194
Nome #
Determinazione quantitativa simultanea di paracetamolo, caffeina ed aspirina nelle compresse. Saggio limite quantitativo per l'acido salicilico. 978
Manuale di analisi qualitativa. Con e-book 652
Analisi Farmaceutica Qualitativa 492
1,3,4-Thiadiazole derivatives as antibacterial and antifungal agents. 394
Antimycobacterial activity of new 1,4-Benzoxazine-2-one derivatives and its 2-(arylamino)-4-oxobut-2-enoate, ring-open analogues. 346
Antimycobacterial activity of new 3,5-disubstituted 1,3,4-oxadiazol-2(3H)-one derivatives. Molecular modeling investigations 310
A 3D-Pharmacophore Model for σ2 Receptors Based on a Series of Substituted Benzo[d]oxazol-2(3H)-one Derivatives 304
Improving selectivity preserving affinity: New piperidine-4-carboxamide derivatives as effective sigma-1-ligands 287
Stability of a novel Lidocaine, Adrenaline and Tetracaine sterile thermosensitive gel: A ready-to-use formulation 279
Antimycobacterial activity of new N1-[1-[1-aryl-3-[4-(1H-imidazol-1-yl)phenyl]-3-oxo]propyl]-pyridine-2-carboxamidrazone derivatives 271
DETERMINAZIONE QUANTITATIVA DI FENOBARBITALE, FENITOINA E MEFOBARBITALE NELLE COMPRESSE MEDIANTE HPLC. 260
Antifungal and antimycobacterial activity of new N1-[1-aryl-2-(1H-imidazol-1-yl and 1H-1,2,4-triazol-1-yl)-ethylidene]-pyridine-2-carboxamidrazone derivatives: a combined experimental and computational approach 254
Antifungal and antimycobacterial activity of 1-(3,5-diaryl-4,5-dihydro-1H-pyrazol-4-yl)-1H-imidazole derivatives. 254
Antifungal and antimycobacterial activity of new imidazole and triazole derivatives. A combined experimental and computational approach 252
Discovery of new potent dual sigma receptor/GluN2b ligands with antioxidant property as neuroprotective agents 249
Computer-assisted design, synthesis, binding and cytotoxicity assessments of new 1-(4-(aryl(methyl)amino)butyl)-heterocyclic sigma 1 ligands 247
Synthesis and receptor binding studies of some new arylcarboxamide derivatives as sigma-1 ligands 239
Substituted benzo[d]oxazol-2(3H)-one derivatives with preference for the σ1 binding site 237
Design, synthesis and antimycobacterial activity of benzoxazinone derivatives and open-ring analogues: preliminary data and computational analysis 235
Antihypertensive activity of arylidenaminoguanidine derivatives. 234
Imidazole and 1,2,4-Triazole-based Derivatives Gifted with Antitubercular Activity: Cytotoxicity and Computational Assessment 227
Another Brick in the Wall. Validation of the σ1Receptor 3D Model by Computer-Assisted Design, Synthesis, and Activity of New σ1Ligands 222
Synthesis, Cytotoxicity Evaluation, and Computational Insights of Novel 1,4-Diazepane-Based Sigma Ligands 222
Synthesis, biological evaluation, and three-dimensional in silico pharmacophore model for sigma1 receptor ligand based on a series of benzo[d]oxazol-2(3H)-one derivatives 215
1-Substituted 3-(ω-aminoalkyl)-1H-indole derivatives as possibile s ligands. 214
New piperidine-based derivatives as sigma receptor ligands. Synthesis and pharmacological evaluation 212
Potential antihypertensive agents. IV. Aminoguanidine and hydrazinopyrimidine derivatives. 207
In-vitro antimycobacterial activity of new synthetic amidrazone derivatives 204
Antimycobacterial activities of N1-[1-[3-aryl-1-(pyridin-2-,3-, or 4-yl)-3-oxo]propyl]-2-pyridinecarboxamidrazones. 201
Synthesis and antimycobacterial activity of [5-(pyridin-2-yl)-1,3,4-thiadiazol-2-ylthio]acetic acid arylidene-hydrazide derivatives 196
Aminoguanidine and amidrazone derivatives, potential antihypertensive agents. 196
Determinazione mediante HPLC dell'acido gentisico nelle urine di soggetti trattati con aspirina 195
SYNTHESIS AND ANTIMYCOBACTERIAL PROPERTIES OF AMIDRAZONE DERIVATIVES. 195
Homology Model and Docking-Based Virtual Screening for Ligands of the σ1 Receptor 193
2-PYRIDINCARBOXYAMIDRAZONE DERIVATIVES STRUCTURALLY RELATED TO AZOLE ANTIFUNGAL AGENTS. 191
Synthesis and antifungal activity of (9/)-1-(5-aryl-3-pyridin-2-yl-4,5-dihydro-pyrazol-1-yl)-2-imidazol-1-yl-ethanone derivatives. 190
Synthesis and antihypertensive activity of some aminoguanidine and amidrazone derivatives 190
Antimycobacterial activity of new 3-substituted 5-(pyridin-4-yl)-3H-1,3,4-oxadiazol-2-one and 2-thione derivatives. Preliminary molecular modelling investigations 189
Synthesis, antifungal and antimycobacterial activities of new bis-imidazole derivatives, and prediction of their binding to P45014DM by molecular docking and MM/PBSA method 188
Antihypertensive activity of some 1,3,4-tiadiazole derivatives. 187
Antitubercular activity of a new pyridinecarboxamidrazone compound alone and in combination with reference drugs, by MRA and in a macrophage model. 184
Synthesis and antibacterial activity of aminoguanidine and amidrazone derivatives 179
Ion-pair liquid chromatographic assay of angiotensin-converting enzyme activity 177
3D pharmacophore model of σ1 binding site based on a series of substituted benzo[d]oxazol-2(3H)-one derivatives. 177
Exploring new structures in the development of new sigma ligands 177
Synthesis and antimycobacterial activity of (3,4-diaryl-3H-thiazol-2-ylidene)-hydrazide derivatives 173
Anti-tubercular acivity of new coumpounds 173
PEGylation of coenzyme Q10 and in vitro release studies 170
null 168
2-Aryl-3-(1H-azol-1-yl)-1H-indole derivatives: a new class of antimycobacterial compounds. Convetional heating in comparison with MW-assisted synthesis. 166
1-substituted-3-(o-aminoalkyl)-1H-indole derivatives as possible sigma ligands. 166
Overview on σ1 receptor: a 3D homology model to solve a part of the enigma. 160
Antifungal and antimycobacterial activity of new imidazole and triazole derivatives. A combined experimental and computational approach. 160
Simultaneous quantitation of paracetamol, caffeine and propyphenazone by high-pressure liquid chromatography 159
Synthesis and antibacterial activity of aminoguanidine and amidrazone derivatives. 157
Wet-dry-wet drug screen leads to the synthesis of TS1, a novel compound reversing lung fibrosis through inhibition of myofibroblast differentiation 151
Design, synthesis and biological profile of new piperidine-4-carboxamide as effective sigma ligands 150
3-Piperidin-4-yl-methyl-3H-benzoxazol-2-one derivatives as sigma ligands. 149
Synthesis and antimycobacterial activity of some N1-[1-[3-aryl-1-(pyridin-2-,3-, or 4-yl)-3-oxo]propyl]-2-pyridinecarboxamidrazones 145
"Sintesi ed attività antimicobatterica di derivati 2-piridincarbossamidrazonici di 1-[4-(1H-imidazol-1-il)fenil]-3-arilpropanonni." 144
Synthesis and antimycobacterial activity of 1,3,4-oxadiazol-2-one derivatives 142
Benzoxazinones and correlated scaffolds linked to benzylamino moieties through a butylene spacer. New sigma receptor ligands 141
Antitubercular activity of novel 3-(2-oxo-2-arylethylidene)-3,4-dihydro-2H-benzo[b][1,4]oxazin-2-ones derivatives 141
Synthesis and antifungal activity of some amidrazone derivatives 139
Cytotoxicity Profiles and Neuroprotective Properties of the Novel Ifenprodil Analogues as Sigma Ligands 137
Synthesis and antimycobacterial activity of some 4H-1,2,4-triazin-5-one derivatives 136
DERIVATI AMIDRAZONICI E 1,2,4-TIADIAZOLICI AD ATTIVITÀ ANTIIPERTENSIVA. 136
Substituted benzylaminoalkylindoles with preference for the σ2 binding site 133
DETERMINAZIONE QUANTITATIVA DI GUANABENZ E MEFRUSIDE MEDIANTE HPLC. 133
Determinazione quantitativa della carbamazepina nelle compresse mediante HPLC in fase inversa. 133
Synthesys and antimycobacterial activity of some 4H-1,2,4-triazin-5-one derivatives 132
DETERMINAZIONE DELL’AMIODARONE E DEL DESETILAMIODARONE NEL SIERO UMANO MEDIANTE HPLC. 132
“Progettazione, sintesi e valutazione dell’attività antimicobatterica ed antifungina di nuovi derivati imidazolici e triazolici. Studio correlato di molecular modeling.” 132
The sigma-enigma. A multistep homology modeling of sigma1 receptors 131
Design, synthesis and SAR analysis of novel selective sigma1 ligands (Part 2) 130
Progettazione e sintesi di nuovi derivati bis-imidazolici ad attività antifungina ed antimicobatterica 129
Simultaneous determination of amiodarone and desethylamiodarone in human plasma by high-pressure liquid chromatography. 128
Synthesis and antimycobacterial activity of some 4-pyridinecarboxyamidrazone derivatives 127
Synthesis and antimycobacterial properties of amidrazone derivatives (II) 126
Enantioselective chromatography and absolute configuration of N,N-dimethyl-3-(naphthalen-2-yl)-butan-1-amines: potential sigma1 ligands. 124
Synthesis and antimycobacterial activity of 5-aryl-1-isonicotynoyl-3-(pyridin-2-yl)-4,5-dihydro-1H-pyrazole derivatives. 123
Simultaneous determination of phenobarbital, phenytoin and methylphenobarbital in tablet formulations by HPLC 123
Arylidene Derivatives of 4-Pyridincarboxamidrazone as Antimycobacterial Agents. 123
SYNTHESIS, MOLECULAR MODELING AND EXPERIMENTALACTIVITY OF SOME NEW ACETAMIDE, BENZAMIDE ANDPHENYLMETHANONE DERIVATIVES AS SIGMA LIGANDS. 123
Preliminary evaluation of in-vitro antimycobacterial properties of N1-(aryliden)-2-pyridincarboxamidrazones 122
High-pressure liquid chromatographic analysis of paracetamol, caffeine and acetylsalicylic acid in tablets. Salicylic acid quantitation 122
Benzossazol-2-oni e benzotiazol-2-oni come possibili ligandi sigma. 122
A new class of substituted benzo[d]oxazole-2(3H)-one derivatives as sigma1 ligands. 122
Molecular modeling in drug design. New chemicals with antibacterial, antitubercular and antifungal activity: synthesis and MIC evaluatiotn. Experimental and computational approach. 122
Novel 1,4-Benzoxazin-3-One Derivatives as Potential Antitubercular Compounds Targeting MenB Enzyme 122
Synthesis and antimicrobial activity of some 2,5-disubstituted 1,3,4-thiadiazole derivatives 121
Synthesis and antimycobacterial activity of some 2-pyridinecarboxyamidrazone derivatives 119
Synthesis and antimycobacterial activity of some indole derivatives of pyridine-2-carboxamidrazone and quinoline-2-carboxamidrazone 118
SYNTHESIS AND ANTIMYCOBACTERIAL PROPERTIES OF 2-PYRIDINCARBOXAMIDRAZONE DERIVATIVES. 117
ARYLIDENE DERIVATIVES OF 2- AND 4-PYRIDINCARBOXYAMIDRAZONE AS POSSIBILE ANTIMYCOBACTERIAL AGENTS. 116
Rapid HPLC analysis for quantitative determination of aristolochic acids 112
Design, synthesis and biological evaluation of novel aminopropylcarboxamide derivatives as sigma ligands 111
“Synthesis and antimycobacterial activity of (3,4-diaryl-3H-thiazol-2-ylidene)-hydrazide derivatives.” Il Farmaco, 58 (2003) 631-637. 111
SYNTHESIS AND ANTIMYCOBACTERIAL PROPERTIES OF CYCLIC AMIDRAZONE DERIVATIVES. 111
Determinazione quantitativa simultanea di paracetamolo, caffeina e propifenazone nelle compresse. 111
Totale 19.126
Categoria #
all - tutte 69.143
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.143


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021556 0 0 0 0 0 0 0 0 0 252 91 213
2021/20222.041 69 175 127 369 45 177 136 78 235 182 116 332
2022/20232.770 212 252 175 295 269 469 40 223 301 334 132 68
2023/20241.507 111 76 120 105 218 129 150 240 43 86 131 98
2024/20252.764 55 68 105 242 276 403 126 195 360 275 288 371
2025/20266.700 589 444 773 708 548 750 1.004 264 788 832 0 0
Totale 25.791